Our company faced the challenge of evaluating the participation/investment in a young company from the Organ on Chip model. We approached Hossein and AZAR Innovations respectively for the assessment and analysis of the product. In several dialogues with the company and their customers, AZAR Innovations analyzed the key features of the product solutions and their market. The preparation of the results was very important for us. On the one hand, a team of specialists from the pharmaceutical segment was able to follow the statements, but there was also a meaningful "translation" for the business management department, so that the product and the results as well as challenges were understood here as well. We absolutely had a positive experience with AZAR Innovations, we are sticking to the cooperation and want to deepen it further.